An infectious disease test developer has raised $1.9 million in a series B financing round to advance its MRSA screening panel. It will also use the funds to develop its new molecular diagnostic ...

bioMérieux, French manufacturer of diagnostic solutions, has received FDA 510(k) approval for NucliSENS EasyQ MRSA, an automated molecular test for MRSA, according to a company news release. The test ...

Diagnostics company bioMerieux (PARIS:BIM) has received 510(k) clearance from the U.S. Food and Drug Administration for a test to detect and screen for methicillin-resistant staphylococcus, more ...

September 13, 2009 (San Francisco, California) — Universal screening using rapid polymerase chain reaction (PCR) analysis for methicillin-resistant Staphylococcus aureas (MRSA) in hospitals appears to ...

Polymerase chain reaction testing may be more clinically effective than chromogenic agar for MRSA screening, according to research published in BMC Infectious Diseases. For their study, researcher ...

Jan. 27, 2003 — Screening for methicillin-resistant Staphylococcus aureus (MRSA) infections is beneficial in patients admitted to the intensive care unit (ICU), according to the results of a ...

Molecular Detection Inc. (MDI), a company developing Detect-Ready™ assays designed to increase the speed and accuracy of infectious disease diagnosis, has announced that its Detect-Ready MRSA assay ...

Screening for the MRSA superbug is being extended to include all patients admitted to Shropshire's two main hospitals, whether they are routine or emergency cases.Screening for the MRSA superbug is ...

There has been a sharp rise in cases of the superbug MRSA being contracted outside hospitals across the UK. Britons have been urged to avoid sharing items such as towels or razors, particularly in ...